Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation☆

Cancer Statistics, 2001

Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2001 · 3.3K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125

Salim E. Kabawat, Robert C. Bast, Atul K. Bhan et al. · International Journal of Gynecological Pathology · 1983 · 598 citations

Medicine, Gynecology, Pathology +16

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers

Steven J. Skates, Fengji Xu, Yinhua Yu et al. · Cancer · 1995 · 230 citations · Full text

Medicine, Gynecology, Oncology +16

Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal Markers

Steven J. Skates, Donna K. Pauler, Ian Jacobs · Journal of the American Statistical Association · 2001 · 152 citations

Medicine, Biostatistics, Oncology +17

Serum Half-Life of CA 125 during Early Chemotherapy as an Independent Prognostic Variable for Patients with Advanced Epithelial Ovarian Cancer: Results of a Multicentric Italian Study

Angiolo Gadducci, Paolo Zola, Fabio Landoni et al. · Gynecologic Oncology · 1995 · 89 citations

Medicine, Gynecology, Oncology +13